Physician profile
Concha Sitter
NPI 1629167713
$3,692.07
in general payments reported to CMS, 2019-2025
16 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $579 · 2022: $620 · 2023: $1,126 · 2024: $955 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442 · Education: $50.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,442.17 |
| Education | $50.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $906.01 | 2021-2025 | |
| Janssen Biotech, INC. | $885.42 | 2021-2025 | Stelara, Simponi Aria, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $570.47 | 2021-2025 | Xifaxan, Trulance, Uceris |
| Takeda Pharmaceuticals U.S.A., INC. | $381.17 | 2021-2024 | Entyvio, Gattex, Eohilia |
| Gilead Sciences, INC. | $230.67 | 2021-2025 | |
| Madrigal Pharmaceuticals | $212.05 | 2024-2025 | Rezdiffra, Resmetirom |
| Celgene Corporation | $187.96 | 2023-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $100.43 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $52.00 | 2024 | Dificid |
| Ferring Pharmaceuticals INC. | $35.90 | 2021-2023 | Rebyota |
| Braintree Laboratories, INC. | $30.52 | 2021-2023 | Sutab |
| Ipsen Biopharmaceuticals, INC | $25.47 | 2025 | Iqirvo |
| Aimmune Therapeutics, INC. | $24.27 | 2025 | Zenpep |
| Axonics, INC. | $18.80 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.84 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Concha Sitter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.